je.st
news
Allergan announces positive results from AVYCAZ Phase III studies for treatment of cUTI
2015-09-03 07:58:28| Biotech - Topix.net
Allergan plc. today announced positive topline results from RECAPTURE 1 and 2, the pivotal Phase III studies evaluating the antibiotic AVYCAZ as a treatment for adult hospitalized patients with complicated urinary tract infections , including pyelonephritis.
Tags: of
results
iii
positive
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|